Abstract
Background
Smokers are often reluctant to quit because they fear long-lasting withdrawal. Yet little research prospectively examines smokers’ withdrawal longer than 1 month post-quit.
Purpose
The aim of this study was to compare successful versus unsuccessful quitters’ withdrawal, positive affect/pleasure, and lifestyle at 1 year post-quit.
Methods
Smokers (N = 572) in a cessation trial completed ecological momentary assessments four times a day for 1 week pre-quit, 1 week post-quit, and 1 week at 1 year post-quit.
Results
From pre-quit to 1 year later, only quitters reported sizeable declines in craving and restlessness, and fewer stressful events. At 1 year, quitters, on average, reported no significant craving. Continuing smokers reduced their cigarette consumption considerably from pre-quit to 1 year later.
Conclusions
Contrary to smokers’ worries, long-term quitters reported less craving and restlessness than when they smoked (perhaps because cessation eliminates the acute nicotine withdrawal smokers experience between cigarettes). This information may encourage smokers to quit and endure withdrawal.
Similar content being viewed by others
References
Asher MK, Martin RA, Rohsenow DJ, MacKinnon SV, Traficante R, Monti PM. Perceived barriers to quitting smoking among alcohol dependent patients in treatment. J Subst Abuse Treat. 2003; 24(2): 169-174.
Hendricks PS, Wood SB, Baker MR, Delucchi KL, Hall SM. The Smoking Abstinence Questionnaire: Measurement of smokers’ abstinence-related expectancies. Addiction. 2011; 106(4): 716-728.
McKee SA, O’Malley SS, Salovey P, Krishnan-Sarin S, Mazure CM. Perceived risks and benefits of smoking cessation: Gender-specific predictors of motivation and treatment outcome. Addict Behav. 2005; 30(3): 423-435.
Orleans CT, Rimer BK, Cristinzio S, Keintz MK, Fleisher L. A national survey of older smokers: Treatment needs of a growing population. Health Psychol. 1991; 10(5): 343-351.
Solway ES. The lived experiences of tobacco use, dependence, and cessation: Insights and perspectives of people with mental illness. Health Soc Work. 2011; 36(1): 19-32.
Weinberger AH, Mazure CM, McKee SA. Perceived risks and benefits of quitting smoking in non-treatment smokers. Addict Res Theory. 2010; 18(4): 456-463.
Hughes JR. Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine Tob Res. 2007; 9(3): 315-327.
Piasecki TM, Fiore MC, Baker TB. Profiles in discouragement: Two studies of variability in the time course of smoking withdrawal symptoms. J Abnorm Psychol. 1998; 107(2): 238-251.
Piasecki TM, Niaura R, Shadel WG, et al. Smoking withdrawal dynamics in unaided quitters. J Abnorm Psychol. 2000; 109(1): 74-86.
Hughes JR. Tobacco withdrawal in self-quitters. J Consult Clin Psychol. 1992; 60(5): 689-697.
Gritz ER, Carr CR, Marcus AC. The tobacco withdrawal syndrome in unaided quitters. Br J Addict. 1991; 86(1): 57-69.
Shiffman S. How many cigarettes did you smoke? Assessing cigarette consumption by global report, Time-Line Follow-Back, and ecological momentary assessment. Health Psychol. 2009; 28(5): 519-526.
Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. 2008; 4: 1-32.
Hendricks PS, Ditre JW, Drobes DJ, Brandon TH. The early time course of smoking withdrawal effects. Psychopharmacology (Berl). 2006; 187(3): 385-396.
Parrott AC. Does cigarette smoking cause stress? Am Psychol. 1999; 54(10): 817-820.
Piper ME, Smith SS, Schlam TR, et al. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry. 2009; 66(11): 1253-1262.
Piper ME, Schlam TR, Cook JW, et al. Tobacco withdrawal components and their relations with cessation success. Psychopharmacology (Berl). 2011; 216(4): 569-578.
McCarthy DE, Piasecki TM, Fiore MC, Baker TB. Life before and after quitting smoking: An electronic diary study. J Abnorm Psychol. 2006; 115(3): 454-466.
Piper ME, Federman EB, McCarthy DE, et al. Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects. J Abnorm Psychol. 2008; 117(1): 94-105.
Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol. 1988; 54(6): 1063-1070.
Welsch SK, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB. Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol. 1999; 7(4): 354-361.
Shiffman S, Khayrallah M, Nowak R. Efficacy of the nicotine patch for relief of craving and withdrawal 7–10 weeks after cessation. Nicotine Tob Res. 2000; 2(4): 371-378.
Olejnik S, Algina J. Generalized Eta and Omega squared statistics: Measures of effect size for some common research designs. Psychol Methods. 2003; 8(4): 434-447.
Bakeman R. Recommended effect size statistics for repeated measures designs. Behav Res Methods. 2005; 37(3): 379-384.
Cohen J. A power primer. Psychol Bull. 1992; 112(1): 155-159.
Cohen J, Cohen P, West SG, Aiken LS. Applied multiple regression/correlation analysis for the behavioral sciences. 3rd ed. Mahwah: Lawrence Erlbaum; 2003; 354-357.
Chassin L, Presson CC, Sherman SJ, Kim K. Long-term psychological sequelae of smoking cessation and relapse. Health Psychol. 2002; 21(5): 438-443.
Solomon RL, Corbit JD. An opponent-process theory of motivation. II. Cigarette addiction. J Abnorm Psychol. 1973; 81(2): 158-171.
Parrott AC. Acute pharmacodynamic tolerance to the subjective effects of cigarette smoking. Psychopharmacology (Berl). 1994; 116(1): 93-97.
Parrott AC. Nicotine psychobiology: How chronic-dose prospective studies can illuminate some of the theoretical issues from acute-dose research. Psychopharmacology (Berl). 2006; 184(3–4): 567-576.
Hughes JR. Craving among long-abstinent smokers: An Internet survey. Nicotine Tob Res. 2010; 12(4): 459-462.
Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB. Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. J Abnorm Psychol. 2003; 112(1): 14-27.
Fiel SB. Chronic obstructive pulmonary disease. Mortality and mortality reduction. Drugs. 1996; 52(Suppl 2): 55-61.
Godtfredsen NS, Holst C, Prescott E, Vestbo J, Osler M. Smoking reduction, smoking cessation, and mortality: A 16-year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies. Am J Epidemiol. 2002; 156(11): 994-1001.
Godtfredsen NS, Vestbo J, Osler M, Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: A Danish population study. Thorax. 2002; 57(11): 967-972.
Hughes JR. Reduced smoking: An introduction and review of the evidence. Addiction. 2000; 95(Suppl 1): S3-S7.
Hughes JR, Carpenter MJ. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res. 2006; 8(6): 739-749.
Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Iniative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 2004; 13: 93-121.
World Health Organization. Composite International Diagnostic Interview. Geneva: World Health Organization; 1990.
Acknowledgments
We would like to thank the staff at the Center for Tobacco Research and Intervention in the UW School of Medicine and Public Health for their help with this research. We are particularly grateful to Stevens S. Smith for statistical advice and to Linda Kurowski and Wendy Theobald for their technical assistance.
Conflict of Interest Statement
Tanya R. Schlam, Megan E. Piper, Jessica W. Cook, and Timothy B. Baker have no potential conflicts of interest to disclose. Over the last 3 years, Dr. Michael C. Fiore has served as an investigator on a research study at the University of Wisconsin that was funded in part by Nabi Pharmacueticals. From 1997 to 2010, Dr. Fiore held a University of Wisconsin named Chair for the Study of Tobacco Dependence, made possible by a gift to University of Wisconsin from GlaxoWellcome.
This research was conducted at the University of Wisconsin-Madison and was supported by grant P50 DA019706 from the National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA); by grant M01 RR03186 from the General Clinical Research Centers Program of the National Center for Research Resources, NIH; by grants 1K05CA139871 and K08DA021311 from NIH; and by the Wisconsin Partnership Program. Medication was provided to participants at no cost under a research agreement with GlaxoSmithKline; no part of this manuscript was written or edited by anyone employed by GlaxoSmithKline. The authors are solely responsible for the analyses, content, and writing of this article. The authors have full control of all primary data, and they agree to allow the journal to review the data if requested.
We declare that this research complies with the current laws of the USA. All participants gave written informed consent prior to entering the study, and the study was approved by the University of Wisconsin Health Sciences Institutional Review Board. Clinical trial registration: NCT00332644 (www.ClinicalTrails.gov).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Schlam, T.R., Piper, M.E., Cook, J.W. et al. Life 1 Year After a Quit Attempt: Real-Time Reports of Quitters and Continuing Smokers. ann. behav. med. 44, 309–319 (2012). https://doi.org/10.1007/s12160-012-9399-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12160-012-9399-9